THE JOURNAL OF INFECTIOUS DISEASES
Dhummakupt A, Siems LV, Singh D, Chen YH, Anderson T, Collinson-Streng A, Zhang H, Patel P, Agwu A and Persaud D.
The Journal of Infectious Diseases. 2018:jiy461-jiy461
Abstract
Background:
High-level expression of the Fcγ receptor, CD32hi, on CD4+ T cells was associated with enhanced HIV infection of the latent reservoir in one study of adults on antiretroviral therapy. We tested the hypothesis that CD32 was the preferential marker of the latentHIV reservoir in virally suppressed, perinatally, HIV-infected adolescents.
Methods:
The frequency of CD32hi CD4+ T cells was determined by flow cytometry (N=5) and the inducible HIV reservoir in both CD32hi and CD32- CD4+ T cells was quantified (N=4) with a quantitative viral outgrowth assay. Viral outgrowth was measured by the standard p24 ELISA and an ultrasensitive p24 assay (Simoa) with lower limits of quantitation.
Results:
We found a 59.55-fold enrichment in the absolute number of infectious cells in the CD32- population compared to CD32hi cells. Exponential HIV replication occurred exclusively in CD32- CD4+ T cells (mean change=17.46 pg/mL, p=0.038). Induced provirus in CD32hi CD4+ T cells replicated to substantially lower levels, that did not increase significantly over time (mean change=0.026 pg/mL, p=0.234), and were only detected by Simoa.
Conclusions:
Our data suggests that the latent HIV reservoir resides mainly in CD32- CD4+ T cells in virally suppressed, perinatally, HIV-infected adolescents, which has implications for reservoir elimination strategies.
Related Posts
Neurology
Comparative Spatial Analyses of the Tumor Immune Landscape in Mouse Models of Glioblastoma Using the PhenoCode Discovery Mouse Neuro Panel and Customized Markers
Poster Background Developing effective therapies for glioblastoma (GBM) relies on robust preclinical animal models that enable detailed investigation of tumor biology, discovery of therapeutic targets, and evaluation of new treatment…
Oncology
Development of a Spatial Metabolic Map of Immunotherapy Sensitive and Resistant Cutaneous Skin Carcinoma
Poster Background Ultrahigh-Plex Single-cell Spatial Phenotyping has revealed valuable insights into the tumor immune microenvironment (TiME) for biomarker discovery and stratification of clinical responses. Metabolic reprogramming is a key hallmark…
Spatial Immunometabolic Profiling of Non-Small Cell Lung Cancer Reveals Distinct Immune Exclusion Patterns and Functional Niches
Analytical validation of a multiplex immunofluorescence 7-Biomarker Immunoprint® assay on the Akoya PhenoImager HT platform for stage I/II Melanoma
Neurology
Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study
Alzheimer’s Research and Therapy | August 26, 2024 Sampani K, Ness S, Tuz-Zahra F, Aytan N, Spurlock EE, Alluri S, Chen X, Siegel NH, Alosco ML, Xia W, Tripodis Y,…
Neurology
Clinical validation of the LucentAD p-Tau 217 as a lab developed test (LDT) for clinical use
Poster The intersection of new therapeutic options for Alzheimer’s disease (AD), the emergence of accurate blood-based tests for AD, and the anticipated health system log jam for confirmatory diagnostic testing…
Neurology
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice
Alzheimer’s & Dementia | August 3, 2024 Verberk IMW, Jutte J, Kingma MY, Vigneswaran S, Gouda MMTEE, van Engelen MP, Alcolea D, Arranz J, Fortea J, Lleó A, Chevalier C,…
Neurology
Discovering novel plasma biomarkers for ischemic stroke: Lipidomic and metabolomic analyses in an aged mouse model
Journal of Lipid Research | August 2, 2024 Becktel DA, Frye JB, Le EH, Whitman SA, Schnellmann RG, Morrison HW, Doyle KP. J Lipid Res. 2024 https://doi.org/10.1016/j.jlr.2024.100614 Abstract Ischemic stroke…